| Literature DB >> 31853303 |
Gang Xu1, Changchun Zhang1, Kun Zhu1, Zhengqi Bao1, Pinghui Zhou1, Xiaojun Li2.
Abstract
Endoscopic removal of nucleus pulposus (NP) of intervertebral disc (IVD) on lumbar intervertebral disc protrusion (LIDP) and its influence on inflammatory factors and immune function were explored. A total of 145 patients with LIDP admitted to The First Affiliated Hospital of Bengbu Medical College from June 2017 to December 2018 were selected and electively treated, in which 87 patients were treated with fenestration discectomy (fenestration group) and 58 patients were treated with endoscopic removal of NP of IVD (minimally invasive group). Effects on patients in the two groups within 6 months after surgery were evaluated by modified MacNab score; differences in surgical related indexes and incidence rates of complications between the two groups were compared; the Oswestry dysfunction score and VAS pain score before treatment, and 1, 3 and 6 months after treatment, and changes of cellular levels of TNF-α, IL-4, IL-6, CD3+, CD4+, and CD8+ before treatment, and 24 and 48 h after surgery were evaluated. Length of surgical incision, intraoperative blood loss, time of operation, time in bed, and hospital stays of patients in minimally invasive group were lower than those in the fenestration group (P<0.05). The Oswestry score and VAS score of patients in minimally invasive group 1, 3 and 6 months after surgery were lower than those in fenestration group (P<0.05). The incidence rate of spinal instability and overall incidence of complications of patients in minimally invasive group were significantly lower than those in fenestration group (P<0.05). Levels of TNF-α and IL-6 of patients in the minimally invasive group 24 and 48 h after surgery were lower than those in the fenestration group (P<0.05) and cellular levels of IL-4, CD3+, CD4+, and CD8+ were higher (P<0.05). In conclusion, endoscopic removal of NP of IVD has good therapeutic effects in patients with LIDP. It reduces inflammation and suppresses immune function with higher safety, worthwhile for clinical use. Copyright: © Xu et al.Entities:
Keywords: endoscopic removal of nucleus pulposus of intervertebral disc; immune function; inflammatory factors; lumbar intervertebral disc protrusion
Year: 2019 PMID: 31853303 PMCID: PMC6909559 DOI: 10.3892/etm.2019.8223
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
General data.
| Variables | Fenestration group (n=87) | Minimally invasive group (n=58) | χ2/t | P-value |
|---|---|---|---|---|
| Sex [n (%)] | 0.168 | 0.682 | ||
| Male | 48 (55.17) | 34 (58.62) | ||
| Female | 39 (44.83) | 24 (41.38) | ||
| Age (years) | 36.75±5.48 | 38.16±5.93 | 1.469 | 0.144 |
| BMI (kg/m2) | 23.75±3.14 | 23.48±3.86 | 0.462 | 0.645 |
| Course of disease (years) | 1.04±0.12 | 1.06±0.14 | 0.919 | 0.360 |
| Pathologic segments [n (%)] | 1.394 | 0.498 | ||
| L3-L4 | 10 (11.49) | 6 (10.34) | ||
| L4-L5 | 45 (51.72) | 25 (43.10) | ||
| L5-S1 | 32 (36.78) | 27 (46.55) | ||
| Prominent types [n (%)] | 0.065 | 0.799 | ||
| Central type | 18 (20.69) | 11 (18.97) | ||
| Peripheral type | 69 (79.31) | 47 (81.03) | ||
| Straight leg raising test [n (%)] | 0.115 | 0.734 | ||
| Positive | 44 (50.57) | 31 (53.45) | ||
| Negative | 43 (49.43) | 27 (46.55) | ||
| Combined with paresthesia [n (%)] | 0.105 | 0.746 | ||
| Yes | 19 (21.84) | 14 (24.14) | ||
| No | 68 (78.16) | 44 (75.86) | ||
| Combined with abnormal movements [n (%)] | 0.070 | 0.791 | ||
| Yes | 15 (17.24) | 11 (18.97) | ||
| No | 72 (82.76) | 47 (81.03) |
BMI, body mass index.
Analysis of clinical efficacy of patients in the two groups [n (%)].
| Variables | Fenestration group (n=87) | Minimally invasive group (n=58) | χ2 | P-value |
|---|---|---|---|---|
| Excellent | 46 (52.87) | 36 (62.07) | 1.198 | 0.274 |
| Good | 28 (32.18) | 17 (29.31) | 0.134 | 0.714 |
| Acceptable | 9 (10.34) | 4 (6.90) | 0.507 | 0.476 |
| Poor | 4 (4.60) | 1 (1.72) | 0.863 | 0.353 |
Figure 1.Analysis of surgical related indicators. (A) Length of surgical incision. (B) The amount of intraoperative blood loss (C) Time of operation. (D) Time in bed. (E) Hospital stays. *P<0.05.
Figure 2.Analysis of Oswestry dysfunction. *P<0.05 compared with that of before surgery; #P<0.05 compared with that of 1 month after surgery; &P<0.05 compared with that of 3 months after surgery; $P<0.05 in the fenestration group at same time.
Figure 3.VAS scores. *P<0.05 compared with that of before surgery; #P<0.05 compared with that of 1 month after surgery; &P<0.05 compared with that of 3 months after surgery; $P<0.05 in the fenestration group at the same time.
Analysis of incidence rate of complications of patients in the two groups [n (%)].
| Variables | Fenestration group (n=87) | Minimally invasive group (n=58) | χ2 | P-value |
|---|---|---|---|---|
| Incision infection | 7 (8.05) | 3 (5.17) | 0.448 | 0.504 |
| Transient nerve paralysis | 10 (11.49) | 2 (3.45) | 2.003 | 0.157 |
| Spinal instability | 7 (8.05) | 0 (0.00) | Fisher | 0.042 |
| Total complications | 24 (27.59) | 5 (8.62) | 7.823 | 0.005 |
Analysis of levels of inflammatory factors after surgery of patients in the two groups (pg/ml).
| Variables | Fenestration group (n=87) | Minimally invasive group (n=58) | t | P-value |
|---|---|---|---|---|
| TNF-α | ||||
| Before surgery | 90.24±9.64 | 91.19±9.14 | 0.593 | 0.554 |
| 24 h after surgery | 68.42±5.25[ | 50.13±4.86[ | 21.164 | <0.001 |
| 48 h after surgery | 51.24±3.43[ | 20.02±2.73[ | 58.106 | <0.001 |
| IL-4 | ||||
| Before surgery | 24.28±3.12 | 23.83±2.87 | 0.878 | 0.381 |
| 24 h after surgery | 35.22±3.02[ | 46.48±1.85[ | 25.381 | <0.001 |
| 48 h after surgery | 40.24±1.88[ | 49.22±1.83[ | 28.477 | <0.001 |
| IL-6 | ||||
| Before surgery | 234.58±28.64 | 233.76±27.15 | 0.172 | 0.863 |
| 24 h after surgery | 164.73±20.42[ | 131.68±17.15[ | 10.163 | <0.001 |
| 48 h after surgery | 92.19±14.32[ | 60.47±12.36[ | 13.787 | <0.001 |
P<0.05 compared with that of before surgery
P<0.05 compared with that of 24 h after surgery.
Changes in postoperative immune function of patients in the two groups (%).
| Variables | Fenestration group (n=87) | Minimally invasive group (n=58) | t | P-value |
|---|---|---|---|---|
| CD3 | ||||
| Before surgery | 58.67±14.75 | 59.43±13.43 | 0.315 | 0.753 |
| 24 h after surgery | 51.36±10.57[ | 55.83±11.39[ | 2.398 | 0.018 |
| 48 h after surgery | 55.85±10.42[ | 59.86±10.27[ | 2.283 | 0.024 |
| CD4 | ||||
| Before surgery | 31.47±7.66 | 30.75±8.15 | 0.540 | 0.590 |
| 24 h after surgery | 24.13±9.07[ | 28.48±8.39[ | 2.914 | 0.004 |
| 48 h after surgery | 29.17±9.83[ | 32.82±11.28[ | 2.064 | 0.041 |
| CD8 | ||||
| Before surgery | 25.12±9.17 | 25.85±9.22 | 0.524 | 0.601 |
| 24 h after surgery | 16.04±7.25[ | 20.79±8.64[ | 3.928 | <0.001 |
| 48 h after surgery | 12.87±5.69[ | 17.13±6.11[ | 4.759 | <0.001 |
P<0.05 compared with that of before surgery
P<0.05 compared with that of 24 h after surgery.